extended-spectrum plactamase-producing Enterobacteriaceae, and Staphylococcus aureus with reduced susceptibility to vancomycin. Here, we report on the susceptibilities of isolates cultured from patients with lower respiratory tract infection to different antibiotics obtained from 20 western and central European hospitals in 1997 and 1998 as part of the SENTRY Antimicrobial surveillance Program. ' In total, 2083 isolates were obtained. The most frequently isolated organisms from patients with lower respiratory tract infection were Staphylococcus aureus and Pseudomonas aeruginosa, comprising 21.0% and 20.3% of the isolates, respectively, followed by Enterobatter Tables 1 and 2 , respectively. Intermediate-resistant penicillin-resistant isolates were obtained from Germany, France, Spain, and Poland. The highly resistant isolates were obtained from Germany, France, and Spain. All isolates, with the exception of two penicillin-resistant Streptococcus pneumoniae isolates from France, were completely susceptible to quinupristin-dalfopristin.
The MI&s, MI&$ and percentage susceptibilities of Enterobacteriaceae and other Gram-negative bacteria for various antibiotics are presented in Tables 3 and  4 , respectively. H. injkenzae was susceptible to all p-lactam and fluoroquinolone antibiotics tested. Based on resistance against ceftazidime, ceftriaxone, or aztreonam, four (2.7%) E. coli isolates and 13 (14.4%) K. pneumoniae isolates carried an extended-spectrum P-lactamase or were overproducers of AmpC.
Resistance to various antibiotics also tended to be higher for isolates from southern Europe, and isolates from hospitalized patients with lower respiratory infection showed markedly higher rates of resistance against most antibiotics compared to isolates from communityacquired pneumonia.4 In comparison to Gram-negative isolates from Latin America, the European isolates generally have clearly higher susceptibilities to almost all antibiotics tested."
With the exception of Acinetobacter spp., the susceptibilities of bacterial isolates cultured from patients with lower respiratory tract infection to various antibiotics still allow adequate treatment with traditional 
